Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Activated sludge from Pharmaceutical industry

ABSTRACT: Activated sludge as Bioresource: screening of secondary metabolite with antimicrobial potential

PROVIDER: PRJNA509315 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Activated sludge from Pharmaceutical industry

Project description:Activated sludge from Pharmaceutical industry Metagenome

| PRJNA509309 | ENA

Practical and Sustainable Modification Method on Activated Carbon to Improve the Decolorization Process in the Acetaminophen Pharmaceutical Industry.

Project description: Not available

| S-EPMC7931432 | biostudies-literature

Project description:Secondary Metabolite Production from Pseudomonas

| PRJNA784595 | ENA

Quality of pharmaceutical industry press releases based on original research.

Project description: Not available

| S-EPMC2518517 | biostudies-literature

Next-Generation Antimicrobial Discovery through Bacterial Self-Screening of Surface-Displayed Peptide Libraries [MiSeq]

Project description:Peptides have great potential to combat antibiotic resistance. While many platforms can screen peptides for their ability to bind to target cells, there are virtually no platforms that directly assess the functionality of peptides. This limitation is exacerbated when identifying antimicrobial peptides, since the phenotype, death, selects against itself, and has caused a scientific bottleneck confining research to only a few naturally occurring classes of antimicrobial peptides. We have used this seeming dissonance to develop Surface Localized Antimicrobial displaY (SLAY); a platform that allows screening of unlimited numbers of peptides of any length, composition, and structure in a single tube for antimicrobial activity. Using SLAY, we screened ~800,000 random peptide sequences for antimicrobial function and identified thousands of active sequences doubling the number of known antimicrobial sequences. SLAY hits present with different potential mechanisms of peptide action and access to areas of antimicrobial physicochemical space beyond what nature has evolved.

2018-01-03 | GSE94530 | GEO

Next-Generation Antimicrobial Discovery through Bacterial Self-Screening of Surface-Displayed Peptide Libraries [HiSeq]

2018-01-03 | GSE94529 | GEO

Pharmaceutical industry effluent diluted 1:500 affects gene expression, CYP1A activity and plasma phosphate in fish

Project description:Patancheru, near Hyderabad, India, is a major production site for the global bulk drug market. About 90 manufacturers send their wastewater to a common treatment plant in Patancheru. Extraordinary high levels of a wide range of pharmaceuticals have recently been demonstrated in the treated effluent. As little as 0.2% of this effluent can strongly reduce the growth rate of tadpoles, but the underlying mechanisms of toxicity are not known. To begin addressing how the effluent affects aquatic vertebrates, rainbow trout (Oncorhynchus mykiss) were exposed to 0.2% effluent for five days. Several physiological endpoints, together with effects on global hepatic gene expression patterns, were analyzed. The exposed fish showed both an induction of hepatic cytochrome P450 1A (CYP1A) gene expression, as well as EROD activity. Clinical blood chemistry analyses revealed an increase in plasma phosphate levels, which in humans indicates impaired kidney function. Several oxidative stress-related genes were induced in the livers, however, no significant changes in antioxidant enzyme activities or in the hepatic glutathione levels were found. Furthermore, estrogen-regulated genes were slightly up-regulated following exposure, and moderate levels of estriol were detected in the effluent. This study identifies changes in gene expression triggered by exposure to a high dilution of the effluent, supporting the hypothesis that these fish are responding to chemical exposure. The pattern of regulated genes may contribute to the identification of mechanisms of sub-lethal toxicity, as well as illuminate possible causative agents.

2009-07-20 | GSE15124 | GEO

Workplace management initiatives and talent engagement in the Nigerian pharmaceutical industry.

Project description: Not available

| S-EPMC7676391 | biostudies-literature

Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market.

Project description: Not available

| S-EPMC4234990 | biostudies-literature

Microbial tyrosinases: promising enzymes for pharmaceutical, food bioprocessing, and environmental industry.

Project description: Not available

| S-EPMC4033337 | biostudies-literature